← All news

TürkiyeResearch and clinical trials

4,914 pregnancies in women with systemic sclerosis studied across Türkiye: miscarriage risk was higher

Peer-reviewed publication

A study published in a journal and reviewed by independent scientists. Even so, a single study is not conclusive; it needs to be replicated.

Under the supervision of the Ministry of Health, pregnancy outcomes of women with systemic sclerosis across Türkiye were studied. In national records, 4,914 pregnancies of 43,663 patients were evaluated. Miscarriage was more common than in women without the disease. This rate was 11.70% in pregnancies before diagnosis and 10.64% in those after diagnosis. The risks of gestational diabetes and high blood pressure in pregnancy also increased.

What does it mean for patients and families?

According to the authors, a successful pregnancy is possible with appropriate team monitoring. It is important for women planning a pregnancy to discuss this in advance with a rheumatologist and an obstetrician-gynecologist.

Source

PubMed (Turkish Journal of Medical Sciences): Pregnancy outcomes in systemic sclerosis before and after diagnosis: a retrospective nationwide cohort study.

Scientific paper: Pregnancy outcomes in systemic sclerosis before and after diagnosis: a retrospective nationwide cohort study. Turkish Journal of Medical Sciences, 2026. DOI: 10.55730/1300-0144.6196 · PubMed 42499451

The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).

This page is translated from the Turkish original.

This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.

The information on these pages is for general information only and does not replace medical advice. Talk to your doctor about diagnosis and treatment decisions. In an emergency in Türkiye, call 112.

Every update is based on an open source and labeled with its level of evidence. No advertising and no drug brand names. Our scientific principles

This page was translated from Turkish by the Doktorclub editorial team.